Re-detectionvs. new acquisition of high-risk human papillomavirus in mid-adult women

Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women

(2016) Patricia Sadate-Ngatchou et al.   SEXUALLY TRANSMITTED DISEASES

Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly

(2015) Tsung-chieh Jane Fu et al.   INTERNATIONAL JOURNAL OF CANCER

Seroprevalence of 8 Oncogenic Human Papillomavirus Genotypes and Acquired Immunity Against Reinfection

(2014) L. Wilson et al.   JOURNAL OF INFECTIOUS DISEASES

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, andTMC6/8 (EVER1/2)variants

(2014) Margaret M. Madeleine et al.   Cancer Medicine

Obesity and Human Papillomavirus Infection in Perimenopausal Women

(2013) S.-H. Liu et al.   JOURNAL OF INFECTIOUS DISEASES

Review: Current knowledge on the role of HPV antibodies after natural infection and vaccination: Implications for monitoring an HPV vaccination programme

(2013) Madelief Mollers et al.   JOURNAL OF MEDICAL VIROLOGY

Prevalence and Risk Factors for Oncogenic Human Papillomavirus Infections in High-Risk Mid-Adult Women

(2013) Rachel L. Winer et al.   SEXUALLY TRANSMITTED DISEASES

Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women

(2012) A. F. Rositch et al.   CANCER RESEARCH

The known unknowns of HPV natural history

(2011) Patti E. Gravitt   JOURNAL OF CLINICAL INVESTIGATION

Serum Antibody Response Following Genital  9 Human Papillomavirus Infection in Young Men

(2011) Z. R. Edelstein et al.   JOURNAL OF INFECTIOUS DISEASES

Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States

(2011) Linda Ahdieh Grant et al.   VACCINE

Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression

(2011) Gareth Adam Maglennon et al.   VIROLOGY

Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients

(2010) K. G. Paulson et al.   CANCER RESEARCH

Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity

(2010) H. Trottier et al.   CANCER RESEARCH

Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection

(2010) Rosalyn Baker et al.   CYTOKINE

Human Papillomavirus Type 16 Variants in Paired Enrollment and Follow‐up Cervical Samples: Implications for a Proper Understanding of Type‐Specific Persistent Infections

(2010) Long Fu Xi et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

(2010) M. Safaeian et al.   JNCI-Journal of the National Cancer Institute

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma

(2009) Joseph J. Carter et al.   JNCI-Journal of the National Cancer Institute

Prevalence and Incidence of HPV Genital Infection in Women

(2009) Christine Velicer et al.   SEXUALLY TRANSMITTED DISEASES

Persistent Antibodies to HPV Virus-Like Particles Following Natural Infection Are Protective Against Subsequent Cervicovaginal Infection with Related and Unrelated HPV

(2009) Zainab A. Malik et al.   VIRAL IMMUNOLOGY

Seroepidemiology of Human Polyomaviruses

(2009) Jaime M. Kean et al.   PLoS Pathogens

WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24–25 January 2008, Geneva, Switzerland

(2008) Morag Ferguson et al.   VACCINE